CNBX PHARMACEUTICALS INC. Share-based Payment Arrangement, Expense
CNBX PHARMACEUTICALS INC. (CNBX) reported Share-based Payment Arrangement, Expense of $0 for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. share-based payment arrangement, expense for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CNBX PHARMACEUTICALS INC. share-based payment arrangement, expense for fiscal 2024 was $139.72K, a 22.58% decline from fiscal 2023.
- CNBX PHARMACEUTICALS INC. share-based payment arrangement, expense for fiscal 2023 was $180.48K, a 75.24% decline from fiscal 2022.
- CNBX PHARMACEUTICALS INC. share-based payment arrangement, expense for fiscal 2022 was $728.87K, a 2058.53% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 12 month |
|---|---|
| 2025-08-31 | $0.00 10-K · filed 2025-12-01 |
| 2024-08-31 | $139.72K 10-K · filed 2025-12-01 |
| 2023-08-31 | $180.48K 10-K · filed 2024-11-29 |
| 2022-08-31 | $728.87K 10-K · filed 2023-11-30 |
| 2021-08-31 | $33.77K 10-K · filed 2022-11-30 |
| 2020-08-31 | $72.12K 10-K · filed 2021-11-29 |
| 2019-08-31 | $247.31K 10-K · filed 2020-11-04 |
| 2018-08-31 | $1.85M 10-K · filed 2019-11-29 |
| 2017-08-31 | $880.79K 10-K · filed 2018-11-29 |
| 2016-08-31 | $29.85K 10-K · filed 2017-12-08 |